AtlasGen Novel Drug Designer: Design Clinical Success Into New Drug Discovery from Day One

AtlasGEN efficiently identifies new molecules based on favorable chemical properties and simultaneously evaluates them for clinical safety and effectiveness based on biology using VeriSIM Life’s groundbreaking Translational Index™ technology. With AtlasGEN, pharmaceutical companies can take advantage of AI-driven drug design chemistry with biological validation to discover clinically successful novel therapies at the beginning of the drug design process. It reduces the time and cost associated with other computational hit discovery approaches, while compressing the hit-to-lead refinement and optimization process. Download the white paper to learn more.

Download the Report